Company Quick10K Filing
Systemax
10-Q 2021-03-31 Filed 2021-05-07
10-K 2020-12-31 Filed 2021-03-18
10-Q 2020-09-30 Filed 2020-10-30
10-Q 2020-06-30 Filed 2020-07-31
10-Q 2020-03-31 Filed 2020-05-05
10-K 2019-12-31 Filed 2020-03-13
10-Q 2019-09-30 Filed 2019-11-01
10-Q 2019-06-30 Filed 2019-08-06
10-Q 2019-03-31 Filed 2019-05-07
10-K 2018-12-31 Filed 2019-03-14
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-07
10-Q 2018-03-31 Filed 2018-05-08
10-K 2017-12-31 Filed 2018-03-15
10-Q 2017-09-30 Filed 2017-11-07
10-Q 2017-06-30 Filed 2017-08-08
10-Q 2017-03-31 Filed 2017-05-11
10-K 2016-12-31 Filed 2017-03-16
10-Q 2016-09-30 Filed 2016-11-07
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-03-17
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-06
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-03-13
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-05
10-Q 2014-03-31 Filed 2014-05-06
10-K 2013-12-31 Filed 2014-03-12
10-Q 2013-09-30 Filed 2013-11-05
10-Q 2013-06-30 Filed 2013-08-09
10-Q 2013-03-31 Filed 2013-05-07
10-K 2012-12-31 Filed 2013-03-14
10-Q 2012-09-30 Filed 2012-11-06
10-Q 2012-06-30 Filed 2012-08-07
10-Q 2012-03-31 Filed 2012-05-08
10-K 2011-12-31 Filed 2012-03-08
10-Q 2011-09-30 Filed 2011-11-10
10-Q 2011-06-30 Filed 2011-08-11
10-Q 2011-03-31 Filed 2011-05-12
10-K 2010-12-31 Filed 2011-03-17
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-12
10-Q 2010-03-31 Filed 2010-05-13
10-K 2009-12-31 Filed 2010-03-18
8-K 2020-10-27
8-K 2020-07-28
8-K 2020-06-01
8-K 2020-04-28
8-K 2020-02-25
8-K 2019-10-29
8-K 2019-07-30
8-K 2019-06-03
8-K 2019-04-30
8-K 2019-02-26
8-K 2019-01-07
8-K 2018-12-17
8-K 2018-12-10
8-K 2018-10-30
8-K 2018-10-05
8-K 2018-08-31
8-K 2018-07-31
8-K 2018-07-30
8-K 2018-07-11
8-K 2018-06-14
8-K 2018-06-04
8-K 2018-05-01
8-K 2018-02-27

Systemax Financials

SYX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1269711114613315113513917318116015313416513314413621516316515215014416017618414197303295709198
Accounts Receivable2552692822782702972952802883333673523403563223203062662452282282141521621641741861908884929696
Inventory34037238735531136732529228532232633129629027325021814413312612014111812312313213112691107106101102
PP&E7171697171183616059186575854173404038148373433921616156615151455151518
Assets874890957958913962901857892942955940878895820805749710621593572566456485503551520474528530358390400
Accounts Payable335337366372311405360318346419442420371420393382347346274263250260169175179196203188105101111117120
Long-Term Debt810976665543342221100
Liabilities434435490496432516467429468536551539486535494504460456382364351352246261267340296277157392214233234
Stockholders' Equity440454467462481446434428424406404401392360326302289254238229222214210224236212224197371138144156166
Income Statement ($MM)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue901979914850846935881806792874873913825913786740699465430421415415302313319331355363236218232249244
Cost of Revenue770839783732727815758689674745746779708788678628599378346339337333232222230242258262154145152163160
Gross Profit131140131118119120123117118129128134118124108112101878382788271929088971018273808684
R&D
SG&A112118118118119127125120116125127134118127122112106-18280807258707269777663676667
Tax753-1-16-20-3-18181-0-48211102224224-14684355
Net Income11157-214-27-6-6-12-20-32-3-26-29-28-10-12-17-7-61-181411341518179101513
Cash Flow ($MM)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-281541-928-1093611-201-1837-612-5134-354-111-018181216-0-36242615
Cash Investing-3-2-5-4-1-3-4-3-4-2-8-1-2-29-1-1-1-1-0-0-1-10-1-0-1248-1-1-4
Cash Financing00-0-1-10-0-1-1-1-1-0-1-1-0-1-1-0-0-2-2-2-4-3-4-60-42-10-248-4-4